Menlo Ventures

Founded in 1976 and headquartered in Menlo Park and San Francisco, Menlo Ventures is one of Silicon Valley's longest-running venture capital firms, with a multi-stage strategy spanning seed through growth. The firm invests across artificial intelligence, bio + healthcare, consumer, cybersecurity, fintech, infrastructure, robotics + hardware, SaaS, and supply chain + automation, with AI now its central thesis (backing Anthropic, Pinecone, and Abnormal AI, among others). Menlo deploys capital through several vehicles: its flagship early-stage fund (seed/Series A), the Inflection fund for the "venture gap" (Series B/C, $20–40M checks into companies with under ~$10M revenue), and the $100M Anthology Fund (a partnership with Anthropic making pre-seed to Series A AI investments, with rolling applications and ~two-week response times). Early checks typically range from roughly $100K to $10M. In October 2025, Menlo raised $1.35B across two new funds—its seventeenth flagship vehicle (~$700M target) and Inflection IV (~$800M target)—lifting assets under management to approximately $6.8B. The firm primarily invests in the U.S., with selective activity in Israel. Best fit for founders raising priced rounds from a lead investor seeking board involvement.